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Physical Exercise for Patients
Undergoing Hematopoietic Stem Cell
Transplantation: Systematic Review
and Meta-Analyses of Randomized
Controlled Trials
Inge E.P.M. van Haren, Hans Timmerman, Carin M. Potting,
Nicole M.A. Blijlevens, J. Bart Staal, Maria W.G. Nijhuis-van der Sanden
Background. The treatment-related burden for patients undergoing hematopoi-
etic stem cell transplantation (HSCT) may be relieved by physical exercises.
Purpose. The purpose of this study was to summarize and analyze the evidence
provided by randomized controlled trials (RCTs) on physical exercise interventions
among patients with cancer undergoing HSCT.
Data Sources. PubMed, CINAHL, EMBASE, the Cochrane Library, and PEDro
were searched for relevant RCTs up to October 1, 2011.
Study Selection. Two reviewers screened articles on inclusion criteria and
indentified relevant RCTs.
Data Extraction. Two authors assessed the selected articles for risk of bias. Data
extraction was performed by 1 reviewer. Meta-analyses were undertaken to estimate
the outcomes quality of life (QOL), psychological well-being and distress, and fatigue.
Data Synthesis. Eleven studies were included, with study populations consist-
ing of recipients undergoing either an allogeneic or autologous HSCT (n734). Four
studies had low risk of bias. The exercise interventions were performed before,
during, and after hospitalization for the HSCT. Different exercise programs on
endurance, resistance and/or activities of daily living training, progressive relaxation,
and stretching were used. Meta-analyses showed that exercise during hospitalization
led to a higher QOL (weighted mean difference8.72, 95% confidence interval
3.13, 14.31) and less fatigue (standardized mean difference0.53, 95% confidence
interval0.16, 0.91) in patients with an allogeneic HSCT at the moment of discharge
from the hospital. No marked effects were found for psychological well-being and
distress. Individual study results suggested significant positive effects on QOL,
fatigue, psychological well-being and distress, and physical functioning.
Limitations. Prevalent shortcomings in the included studies were the heteroge-
neity among studies and the lack of blinding of participants, personnel, and outcome
assessment.
Conclusions. The results suggest that recipients of HSCT may benefit from
physical exercise.
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Cancer is a leading cause ofdeath worldwide, accountingfor an estimated 7.6 million
deaths (about 13% of all deaths) in
2008.1 Greater understanding of the
disease processes and the develop-
ment of more effective therapies has
resulted in a gradual increase in sur-
vival rates of patients with cancer.2,3
The most effective treatments for
hematological malignancies involve
high-dose chemotherapy and, if
appropriate, total-body irradiation
followed by hematopoietic stem cell
transplantation (HSCT). The use of
HSCT continues to increase as treat-
ment technology improves, which
has resulted in reduced morbidity
and an increased life expectancy.4
Worldwide, about 50,000 people
receive an allogeneic or autologous
HSCT each year, with a concomitant
rise in the number of survivors.4
Despite these promising improve-
ments, the treatment-related burden
of HSCT is still high, with 2 of every
5 patients given allogeneic HSCT for
advanced cancer dying from the
complications.4 Patients experience
considerable physical and functional
deterioration and diminished psy-
chological well-being before, during,
and after HSCT.5
Courneya and Friedenreich6,7 previ-
ously described the treatment-
related psychophysical problems of
patients with cancer in 1999. Cur-
rently, the most relevant and fre-
quently reported problems for
patients with hematological malig-
nancies are reduced physical perfor-
mance and fitness, fatigue, psycho-
logical problems such as distress and
fear, immunologic and hematologic
changes, and complications such
as graft versus host disease (GVHD),
infections, diarrhea, and pain.5
Severe fatigue is considered to be a
significant impairment.8 Prevalence
estimates of fatigue during treatment
for cancer range from 25% to 75%.9
After transplantation, the individu-
al’s quality of life (QOL), social role,
and physical function often are
adversely influenced by difficulties in
reintegrating into the community.5,10
After treatment, patients generally
increase the amount of physical
exercise, but not to the pretreat-
ment level. Consequently, muscular
weakness and cardiorespiratory dys-
function may develop.11 To avoid
cancer-related fatigue, patients are
traditionally advised to rest, mini-
mize strenuous physical effort, and
lower their daily activity in order to
avoid discomfort.8,12 However, these
recommendations may have para-
doxical effects because inactivity
will not return the patient to his or
her previous level of functioning.13
Over the last few years, the number
of reports on the promising role of
physical exercise programs as a
nonpharmacologic adjuvant therapy
for patients with cancer has been
increased. These patients may bene-
fit in terms of improved fitness lev-
els, physical activity, and QOL while
combating the treatment-related
symptoms. In 1986, the first study to
examine the effects of exercise
among patients with acute leukemia
already showed the positive effects
of rehabilitation measures taken after
HSCT.14 Currently, various exercise
interventions can be implemented
before, during, and after cancer
treatment, although a firmer evi-
dence base in support of these pro-
grams is still needed.2,5,15,16
The purpose of this review is to sys-
tematically summarize and analyze
the effects of exercise interventions
administered before, during, and
after HSCT on QOL, psychological
well-being and distress, fatigue, and
physical functioning. This overview
will emphasize the exercise program
and its potential physical and psy-
chosocial benefits.
Method
This systematic review was carried
out according to the PRISMA (Pre-
ferred Reporting Items for System-
atic Reviews and Meta-analyses)
Statement.17
Data Sources and Searches
A comprehensive literature study
was conducted using the electronic
online literature databases PubMed,
CINAHL, EMBASE, the Cochrane
Library, and PEDro to identify rele-
vant randomized controlled trials
(RCTs).
Study Selection
Randomized controlled trials were
considered eligible if they met the
following inclusion criteria: (1) orig-
inal article published before October
1, 2011; (2) involving patients aged
18 years or older diagnosed with can-
cer and undergoing HSCT; (3) phys-
ical exercise being the main compo-
nent of the intervention; and (4)
published in English. The following
key words were used to identify
relevant studies: “Stem cell,” “Stem
cell transplantation,” “Bone marrow
transplantation,” “Hematologic stem
cell transplantation,” “Exercise,”
“Exercise program,” “Exercise test-
ing,” “Physical activity,” “Physical
therapy,” “Physiotherapy,” “Train-




• eFigure 1: Forest Plot of
Weighted Mean Difference, With
95% Confidence Interval, for
Psychological Well-Being and
Distress (Anxiety) Measured With
the Hospital Anxiety and
Depression Scale at Discharge
From the Hospital
• eFigure 2: Forest Plot of
Weighted Mean Difference, With
95% Confidence Interval, for
Psychological Well-Being and
Distress (Depression) Measured
With the Hospital Anxiety and
Depression Scale at Discharge
From the Hospital
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free-text words), and “Randomized
Clinical Trial.” The full search strat-
egy for CINAHL was: (MH “Hemato-
poietic Stem Cells”) OR (MH “Stem
Cells”) OR (MH “Hematopoietic
Stem Cell Transplantation”) OR (MH
“Colony-Forming Units Assay”) OR
“Stem Cell” AND “Exercise.” The
unique articles were checked for rel-
evance. From the selected articles,
the abstracts were read to identify
relevant information. In case of
uncertainty, the full article was read
by 2 independent reviewers (H.T.
and J.B.S.). The selected articles then
were read in full to confirm eligibil-
ity. Additional studies were located
by a manual search using references
from the retrieved articles.
Data Extraction and Quality
Assessment
The Cochrane Collaboration’s tool
for assessing risk of bias was used to
assess the risk of bias.18 Nine items
were scored, and these items were
divided into 6 domains of bias
(Tab. 1),18 with 3 rating categories
available for each item: (1) low risk
of bias, which is unlikely to alter the
results significantly; (2) unclear risk
of bias, which raises some doubt
about the results; and (3) high risk
of bias, which seriously weakens
confidence in the results. When
there was insufficient information on
an item or domain, it was scored as
“high risk.” All selected articles were
scored by 2 authors (H.T. and J.B.S.).
Disagreement between the assessors
was resolved by discussion, and in
case of remaining discussion, a third
assessor (I.vH.) was asked for advice
in order to make a final decision.
Data extraction was performed by
one reviewer (I.vH.) using a stan-
dardized extraction form and con-
trolled by the first rater (H.T.). In
case of obscurity (to avoid potential
errors), correctness of abstraction
and interpretation were discussed
with the first rater.
Data Synthesis and Analysis
Treatment effects were examined
through meta-analyses, which were
conducted only if studies were
thought to be clinically homogenous
and comparable in intervention,
duration, and follow-up moments.
The findings of the individual studies
were analyzed in meta-analyses using
Review Manager (RevMan) soft-
ware.19 Our main outcomes were
QOL, psychological well-being and
distress, fatigue, and physical func-
tioning. Weighted mean differences
(WMDs) and 95% confidence inter-
vals (95% CIs) were calculated for
each of the continuous outcome
variables when equal outcome mea-
sures were used across studies. Stan-
dardized mean differences (SMDs)
were used as a summary statistic
when different outcome measures
were used across studies to measure
the same construct. A P value of
.05 was considered statistically
significant.
Heterogeneity of treatment effects
among studies was investigated
statistically using the heterogeneity
I2 statistic. The degree of heteroge-
neity was graded as low (I225%),
moderate (I225%–75%), or high
Table 1.

































Hacker et al, 201131 High High High High High Low High 1/7
Wiskemann et al, 201132 Low High High High Low Low Low 4/7
Knols et al, 201033 Low Low High Low Low Low Low 6/7
Baumann and colleagues,
2010/201125,26,a
Low Unclear High High Low Low Low 5/7
Shelton et al, 200927 High High High High High Low Low 2/7
Jarden and colleagues,
2009/200923,24,a
Low High High High Low Low Low 4/7
Coleman et al, 200829 High High High High Low Low Low 3/7
DeFor et al, 200730 High High High Low High Low Low 3/7
Kim and Kim,
2005/200621,22,a
Low High High High High Unclear Low 2/7
Coleman et al, 200328 High Low High High High Low High 2/7
Mello et al, 200334 High High High High High Unclear High 0/7
a Both publications represent 1 study.
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(I275%).20 A P value of .05 indi-
cated heterogeneity of treatment
effects. A random-effects model was
used to pool the effects of the stud-
ies, as we expected clinical hetero-
geneity among them.
Results
Figure 1 shows a flowchart of the
selection process for literature
search. After screening of titles and
abstracts, 180 studies (78%) were
excluded out of a total of 232 unique
publications. The remaining 52 pub-
lications were read in full text. After
reading the full article, 14 articles
were included in this review.21–34
Two author groups (Kim and Kim21,22
and Jarden and colleagues23,24) each
published 2 articles using the same
study sample, but focusing on differ-
ent outcomes. One author group
published 2 articles where the sec-
ond article included a subgroup anal-
ysis of their RCT.25,26 Therefore, the
actual total number of included orig-
inal studies for this review was 11.
Assessment of Risk of Bias
The risk of bias of the RCTs is
described in Table 1. The raters
agreed on 58 of the 77 items being
scored in the risk of bias assess-
ments, resulting in a percentage
agreement of 75%. Disagreement
between the assessors was resolved
Figure 1.
PRISMA flow diagram of studies through the systematic review. HSCThematopoietic stem cell transplantation.
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by discussion, and in case of remain-
ing discussion, a third assessor
(I.vH.) was consulted for advice in
order to make a final decision. After
discussion and consulting, 100%
agreement was reached.
The study by Knols et al33 had the
highest score (6 out of 7), corre-
sponding to the lowest risk of bias.
Overall, 4 studies attained a score of
4 out of 7 and had a low risk of bias.
Overall scores of the other studies
were less than 4 out of 7, correspond-
ing to a high risk of bias. Methodolog-
ical shortcomings regarding blinding
of participants and personnel were
present in all studies.21–34 Lack of
blinding of outcome assessments was
present in all except 2 studies.30,33
Other less prevalent shortcomings
were lack of allocation concealment
(8 studies),21–24,27,29–32,34 lack of clarity
regarding random sequence genera-
tion (6 studies),27–31,34 incomplete out-
come data (7 studies),21,22,27,28,30,31,34
and lack of clarity regarding selective
reporting (unclear in 2 studies).21,22,34
Eight studies were considered free
of other problems that could lead
to a high risk of bias.21–27,29,30,32,33
Three studies with low risk of bias
could be pooled in our meta-
analyses.23,26,32 The other studies have
been summarized and described.
Publication Bias
Funnel plots were performed for all
outcomes, and all were symmetri-
cally displayed (plots not shown).
Patient Characteristics
The studies were performed in sev-
eral countries around the world: 5
in the United States,27–31 2 in Ger-
many,25,26,32 1 in Denmark,23,24 1 in
Korea,21,22 1 in Switzerland,33 and 1
in Brazil.34 Table 2 summarizes the
important characteristics and signifi-
cant results of all studies.
A total of 734 patients with different
hematologic malignancies had been
enrolled, with the number included
ranging from 18 to 135. Of the 11
studies, 7 investigated patients receiv-
ing an allogeneic HSCT,21–24,27,30,32,34
2 looked at patients receiving an
autologous HSCT,28,29 and 3 involved
patients receiving either an alloge-
neic or autologous HSCT.25,31,33
Two studies focused only on patients
with multiple myeloma,28,29 and 1
study included only patients with
leukemia or severe aplastic ane-
mia.21,22 The remaining 8 studies
investigated patients with any type
of lymphoma or leukemia.23–27,30–34
Intervention
Four studies implemented the phys-
ical exercise intervention during hos-
pital admission,21–26 and the imple-
mented exercises continued after
hospitalization in 2 studies.30,34 In 3
studies, the intervention programs
started before hospitalization and
continued during hospital admission
as well as after discharge.28,29,32
Three studies implemented the exer-
cise intervention after discharge,
with a follow-up period ranging
from 3 weeks to 6 months after
HSCT.27,31,33
Intervention programs differed
markedly, with 5 studies using a
combination of endurance training
and resistance training.27–29,32,33 One
study investigated resistance exer-
cise only31; another study investi-
gated endurance training only30; a
third study combined endurance
training with dynamic exercises,
progressive relaxation, and psycho-
logical education23,24; a fourth study
combined endurance training with
activities of daily living (ADL) train-
ing25,26; a fifth study examined a
combination of endurance training,
active range of motion, stretching
exercises, and resistive training34;
and the last study investigated a com-
bination of bed exercises and relax-
ation breathing exercises.21,22
Endurance exercise programs mostly
involved walking27,28,30,32,34 (fre-
quently on a treadmill) and
cycling.23–27,32,33 For the resistance
exercises, stretch bands,27–29,31,32
weight machines,27 or free hand and
ankle weights23,24,27,33 were used.
The duration of the programs varied
between 4 weeks27 and approxi-
mately 6 months.28 The control
groups varied as well, with some
controls receiving routine or usual
care,21–24,29–31,33 others offered no
exercise program at all,32,34 and oth-
ers receiving so-called passive and
active mobilization25,26 or being
instructed to exercise at home.27,28
All studies evaluated the effect of the
exercise program postintervention,
although some studies also included
an assessment during the exercise
intervention.28–30,32,34 Two studies
also evaluated the effect of the inter-
vention after follow-up periods of 3
and 6 months.23,24,33
QOL
Quality of life was assessed in 5 stud-
ies.23,25,26,31–33 Three studies23,26,32
had nearly comparable timing and
content of intervention and were
included in the meta-analysis for ana-
lyzing QOL (Fig. 2). These 3 studies
included only patients receiving an
allogeneic HSCT (n148). Jarden et
al23 and Baumann et al26 started their
physical exercise intervention dur-
ing hospitalization. Wiskemann et
al32 started their physical exercise
intervention shortly before hospital-
ization and continued the interven-
tion during the inpatient period and
after hospitalization. The studies
were only comparable and usable for
a meta-analysis at the moment of dis-
charge from the hospital. All 3 stud-
ies used the same QOL question-
naire, the European Organization for
Research and Treatment of Cancer
Quality of Life Questionnaire
(EORTC QLQ-C30), with an overall
score ranging from 0 to 100 points
and a higher score representing a
Physical Exercise for Patients Undergoing Hematopoietic Stem Cell Transplantation
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higher QOL. For the moment of dis-
charge from the hospital, the pooled
analysis of the 3 studies revealed a
significantly higher value for QOL in
the allogeneic intervention group
compared with the allogeneic con-
trol group (n148; WMD8.72;
95% CI3.13, 14.31; P.002). No
heterogeneity for this outcome was
found (I20%, P.68). Follow-up
measurements were performed by
Jarden et al23 at 3 and 6 months
postintervention, and they found
no significant differences between
groups for QOL. Wiskemann et al32
continued the intervention program
for 6 to 8 weeks after discharge from
the hospital and found significant
group differences in favor of the
intervention group for EORTC
“physical functioning” (P.03)
postintervention.
The studies of Hacker et al31 and
Knols et al33 were not eligible for
pooling in a meta-analysis. Although
both studies started the intervention
after discharge from the hospital, the
programs differed in duration and
starting point: duration of 6 weeks
and starting following hospital dis-
charge in the study by Hacker et al31
and duration of 12 weeks and start-
ing from 3 weeks to 6 months after
HSCT in the study by Knols et al.33
Hacker et al31 found no significant
effects between groups for QOL.
Knols et al33 found better scores for
the intervention group on the health-
related QOL outcomes of emotional




Four studies examined the effects of
the exercise intervention on psycho-
logical well-being and dis-
tress.23,28,30,32 One study had the
exercise intervention during hospital
admission,23 a second study started
during the intervention during inpa-
tient period and continued it after
discharge,30 and 2 studies started the
intervention before admission and
continued it during admission and
after discharge.28,32 DeFor et al30
used a self-perception scale of phys-
ical and emotional well-being, with
scores ranging from 1 (very poor) to
10 (very good). Coleman et al28 used
the Profile of Mood States (POMS)




Two studies used the Hospital Anxi-
ety and Depression Scale (HADS) to
measure general anxiety and depres-
sion,23,32 whereas in the study of
Coleman et al,28 an overall score for
mood disturbance was given based
on the sum of the subscales. Pooling
of results, therefore, was not possi-
ble. Although the study by DeFor et
al30 also gave a general single-point
score for well-being, pooling of
results with the study by Coleman et
al28 was not reliable because the
POMS is a far more comprehensive
questionnaire containing 65 items.
Jarden et al23 and Wiskemann et al32
both included aerobic and resis-
tance/ADL training during their
intervention. Because Wiskemann et
al32 continued the exercise program
after hospitalization, the studies
were only comparable and usable for
the meta-analysis at the moment of
discharge from the hospital. The
results of the studies by Jarden et al23
and Wiskemann et al32 were pooled
for the meta-analysis based on the
HADS scores (eFigs. 1 and 2, avail-
able at ptjournal.apta.org). The
HADS score ranges from 0 to 21
points, with a higher score indicat-
ing more severe anxiety and depres-
sion. When analyzing the anxiety
score, no significant effects could be
found at discharge from the hospital
(n115; WMD1.05; 95% CI
3.67, 1.57; P.43). Heterogeneity
was found in this analysis (I2 80%,
P.03). When analyzing the depres-
sion score, no significant effects







Random, 95% CIMean SD Total Mean SD Total Weight
Baumann et al, 201126 68.6 11.2 17 56.3 17.6 16 30.4% 12.30 (2.17, 22.43)
Jarden et al, 200923 61.3 17.2 17 52.9 16.7 17 24.1% 8.40 (3.00, 19.80)
Wiskemann et al, 201132 53.8 19.9 40 47.3 18.1 41 45.5% 6.50 (1.79, 14.79)
Total (95% CI) 74 74 100% 8.72 (3.13, 14.31)
Heterogeneity: tau20.00; 20.76, df2 (P.68), I20%
Test for overall effect: z3.06 (P.002)
Figure 2.
Forest plot of weighted mean difference (WMD), with 95% confidence interval (95% CI) for quality of life measured with the
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) at discharge from the
hospital. IVinverse variance.
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hospital (n115; WMD1.11; 95%
CI2.37, 0.14; P.08). Heteroge-
neity for this outcome was found to
be moderate (I2 38%, P.20). The
study by Jarden et al23 had follow-up
measurements at 3 and 6 months
postintervention. No significant
effects were found for psychological
well-being and distress at these
follow-up moments. Wiskemann et
al32 continued the intervention pro-
gram for 6 to 8 weeks after discharge
from the hospital and found signifi-
cant group differences, with a higher
HADS anxiety score for the interven-
tion group postintervention (P.01).
The meta-analysis showed no signif-
icant effect on psychological well-
being and distress after hospitaliza-
tion. This finding could be
confirmed with the individual results
of the study by Coleman et al,28
where no significant effects also
were found for psychological well-
being and distress. In the study by
DeFor et al30 statistically significant
effects in favor of the intervention




Six studies examined the effects of
the exercise intervention on
fatigue.21,23,27,31–33 Three of them
started the intervention after dis-
charge from the hospital.27,31,33
These studies were not comparable
in the meta-analysis because the
intervention programs differed in
duration (4, 6, and 12 weeks) and
the moment of intervention (imme-
diately after discharge from the hos-
pital and up to 6 months after HSCT).
Three studies implemented their
intervention during admission to the
hospital.21,23,32 The study by Kim and
Kim21 assessed fatigue using the
Piper Fatigue Scale (PFS). The PFS
has no subscale for general fatigue
and could not be used in the meta-
analysis. Therefore, only the studies
by Jarden et al23 and Wiskemann et
al32 were included in the meta-
analysis (Fig. 3).
Different questionnaires—the Func-
tional Assessment of Cancer Therapy–
Anemia Scale (FACT-An)23 and the
Multidimensional Fatigue Inventory
(MFI)32—were used to assess fatigue,
so the SMD was used as a summary
statistic. There was a significant
effect at discharge where the partic-
ipants in the exercise group show
less fatigue (n115; SMD0.53; 95%
CI0.16, 0.91; P.005). No hetero-
geneity for this outcome was found
(I20%; P.73). The meta-analysis
indicated that training during hospi-
talization has a positive effect on
fatigue in patients receiving an allo-
geneic HSCT. This effect could not
be confirmed with the individual
results of the studies by Shelton et
al27 and Knols et al33 because no sig-
nificant effects on fatigue were
found between groups in these stud-
ies. Only Kim and Kim21 and Hacker
et al31 found statistically significant
effects for fatigue in favor of the
exercise group.
Physical Functioning
Ten studies analyzed physical func-
tioning, mostly the strength of mus-
cles (n8) and physical fitness
(n9).23–34 The studies were not
comparable for meta-analyses
because treatment phase and dura-
tion differed. Moreover, outcome
measures were not comparable
because different muscle groups
were assessed, noncomparable phys-
ical fitness measures were used, or
subpopulations differed. Five studies
showed significant effects in favor of
the exercise groups after the inter-
vention concerning strength,23,25,32–34
with 4 studies having low risk of
bias.23,25,32,33 Physical activity and
functional performance were pre-
sented in the studies to analyze phys-
ical fitness outcome measures for
endurance.23–33 Statistically signifi-
cant effects in favor of the exercise
group were found in studies with
low risk of bias for maximum oxygen
consumption,23 Six-Minute Walk
Test (6MWT) scores postinterven-
tion,32 relative endurance over
time,25,26 walking speed over time,33
and functional exercise capacity
over time.33 In studies with high risk
Study or Subgroup




95% CIMean SD Total Mean SD Total Weight
Jarden et al, 200923 33.9 9.7 17 27.8 9 17 29.1% 0.64 (0.05, 1.33)
Wiskemann et al, 201132 12.7 3.6 40 14.7 4.4 41 70.9% 0.49 (0.05, 0.93)
Total (95% CI) 57 58 100.0% 0.53 (0.16, 0.91)
Heterogeneity: tau20.00; 20.12, df1 (P.73), I20%
Test for overall effect: z2.81 (P.005)
Figure 3.
Forest plot of standardized mean difference (SMD), with 95% confidence interval (95% CI) for fatigue at discharge from the hospital.
IVinverse variance.
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of bias, statistically significant effects
were found for the 6MWT,27 15.2-m
(50-ft) walk,27 body weight,28 and
Karnofsky Performance Score
(KPS).30 In the study by Jarden et
al,24 no significant effect for the KPS
was found.
Other Outcome Measures
Significant effects in favor of the
exercise group were found for
requiring fewer attempts at stem
cell collection (Bonferroni adjusted
P.025),29 fewer days of stem cell
collection (Bonferroni adjusted
P.025),29 a better change in lym-
phocyte count,22 fewer days of
parental nutrition,23 and a reduction
in the incidence of diarrhea.33 One
study showed that more GVHD
occurred in the intervention
group.26 The study by Jarden et al24
showed that the exercise group had
more declines in symptom severity
scores over time. No significant
effects were found in the study by
Baumann et al26 for lung function or
hematopoietic parameters. In the
studies by Baumann et al26 and Knols
et al,33 no significant group effects
were found for body composition.
Discussion
Eleven RCTs were identified, and
exercise interventions differed in
duration, type and content of exer-
cise, and timing of the intervention
relative to the HSCT. Moreover, dif-
ferent outcome measures were used.
The results of our meta-analyses sug-
gest that patients receiving an alloge-
neic HSCT may benefit from physical
exercise, including improved QOL
and reduced fatigue, especially at dis-
charge from the hospital. Although
no significant effects could be found
in the meta-analyses for psychologi-
cal well-being and distress, one study
showed positive effects in the inter-
vention group at discharge and at
postintervention. Positive effects
were found for the intervention
group on physical outcomes con-
cerning strength in 5 studies and for
physical activity and performance in
8 studies. The other clinical outcome
measures suggest exercise has a pos-
itive effect on recovery.
The risk of bias of the RCT studies
included in this review appeared to
be moderate to high, and no study
was free of risk of bias. Moreover,
the methodological quality score var-
ied from 034 to 6 out of 7.33 Lack of
methodological rigor also was a lim-
itation described in the previous
reviews on this topic.2,5,15 Method-
ological shortcomings regarding
blinding of participants, personnel,
and outcome assessment are hard to
pursue in these kinds of intervention
studies. To avoid potential bias, we
included only RCTs in this review. In
the previous 2 years, more RCTs of
higher quality and using more valid
and standard measurement methods
have been published, which enabled
us to pool data for meta-analyses.
Therefore, the 3 studies pooled in
our meta-analyses attained a score of
higher than 4 out of 7 and had no
high risk of bias.
The meta-analyses showed a signifi-
cant positive effect at discharge from
the hospital for QOL and fatigue,
which is an important complaint
during treatment for cancer.9 Other
studies also examined the effect of
cancer on fatigue.16,35,36 In the sys-
tematic review by Velthuis et al,16 a
supervised aerobic exercise program
during breast cancer treatment
appeared to be a promising and fea-
sible approach in the management of
fatigue. The study by Cramp and
Daniel36 also demonstrated that aer-
obic exercise is a potentially impor-
tant intervention against fatigue. Our
results from the meta-analyses sup-
port these findings for patients
undergoing allogeneic HSCT, with
the exercise group showing signifi-
cantly less fatigue at discharge from
the hospital than the control group.
Other articles concerning exercise
interventions in patients with cancer
also showed these positive effects
on QOL.6,15,37,38 In previous reviews
analyzing exercise interventions in
patients undergoing HSCT, benefi-
cial effects also were found for
strength, endurance, physical fit-
ness, fatigue, and psychological well-
being.2,5,15 It should be mentioned
that the findings of these previous
reviews must be interpreted with
some caution. The previous reviews
included studies with various study
designs2,5,15 and no restrictions
regarding group size, age, and the
use of a control group. In this
review, the occurrence of GVHD
was reported by one study to be
higher in the exercise group.26 The
authors noted that more patients in
the intervention group underwent
unrelated allogeneic HSCT, which
places them at higher risk of GVHD.
A potential limitation of our review
might be the literature search. Due
to our limitation in searching for
RCTs published in English, it could
be that a potentially relevant study in
another language was missed.
Another limitation was the pooling
of studies in our meta-analyses. The
pooling was limited due to the use of
different intervention programs in
the RCTs, with differences in admis-
sion, follow-up times, and outcome
measures. For our meta-analyses, we
included 3 studies.23,25,32 Two of
them were fully comparable in inter-
vention duration.23,25 Both interven-
tions were conducted during the
inpatient period and lasted approxi-
mately 6 weeks. The intervention in
the third study32 lasted longer,
started shortly before hospitaliza-
tion, and continued after hospitaliza-
tion. Due to these differences in time
and because different time moments
for follow-up across studies further
limited analyzing follow-up measure-
ments, the studies were only compa-
rable in our meta-analysis until the
moment of discharge from the
hospital.
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In this systematic review, the best
results were seen in the meta-
analyses at discharge from the hospi-
tal, suggesting that starting inter-
vention before or just after
transplantation seems to be effec-
tive. Starting intervention after hos-
pitalization seems to be less effec-
tive, as fewer positive results were
found in those studies. Looking at
other patient groups, beneficial
effects of physical exercise before
surgery have been found for func-
tional recovery with fewer complica-
tions afterward, suggesting that the
earlier the intervention starts, the
better.39–41 In the review by Wiske-
mann and Huber,5 tentative recom-
mendations for moderate exercise,
30 minutes per session and 3 to 5
times per week, were given.
Whether to start the exercise before,
during, or after hospitalization is not
made clear in the reviews by Liu et
al,2 Wiskemann and Huber,5 and
Knols et al.15 With our review, we
can suggest that it is beneficial to
start a physical exercise program
before or just after transplantation,
as a positive trend is shown. It is not
possible, however, to give clear
advice for patients undergoing HSCT
on either the best content of the
exercise program or its start, dura-
tion, and intensity, as pooling of
studies in our meta-analyses was
limited. A clear clinical guideline
concerning the start, duration, and
intensity of the exercise program
will require future RCTs that stan-
dardize these variables and use com-
parable outcome domains with sim-
ilar outcome measures.
Nevertheless, the findings in this sys-
tematic review are of important clin-
ical relevance because it is shown
that the exercise interventions were
well tolerated and safe for patients
undergoing an HSCT. It appears that
starting exercise intervention before
or just after transplantation is bene-
ficial because a positive trend is
shown. This review indicates that
physical exercise in aerobic or resis-
tance training is feasible and benefi-
cial in patients undergoing an HSCT.
Exercise can be performed despite
the frequent occurrence of medical
complications. Further support for
exercise as an adjuvant therapy for
patients undergoing an HSCT is pro-
vided, but the optimal formula of the
exercise program is still the subject
of investigation.
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